|
KLHL9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.9169999971046E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.45209999977436E-08 |
| Normal-vs-Stage2 |
3.041900E-04 |
| Normal-vs-Stage3 |
7.70200000000942E-05 |
| Normal-vs-Stage4 |
1.106110E-02 |
| Stage1-vs-Stage2 |
6.347600E-01 |
| Stage1-vs-Stage3 |
9.926200E-01 |
| Stage1-vs-Stage4 |
6.920600E-01 |
| Stage2-vs-Stage3 |
6.421400E-01 |
| Stage2-vs-Stage4 |
4.402800E-01 |
| Stage3-vs-Stage4 |
6.891200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.31489999894075E-08 |
| Normal-vs-AfricanAmerican |
1.81224999999952E-05 |
| Normal-vs-Asian |
1.226850E-04 |
| Caucasian-vs-AfricanAmerican |
7.681400E-01 |
| Caucasian-vs-Asian |
3.090800E-01 |
| AfricanAmerican-vs-Asian |
1.913580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.57749998911328E-09 |
| Normal-vs-Female |
2.574300E-04 |
| Male-vs-Female |
1.328220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.47499999999068E-05 |
| Normal-vs-Extreme_Weight |
5.08730002568569E-09 |
| Normal-vs-Obese |
1.169140E-04 |
| Normal-vs-Extreme_Obese |
2.956900E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.453600E-01 |
| Normal_Weight-vs-Obese |
4.485200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.181400E-01 |
| Extreme_Weight-vs-Obese |
7.950400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.834600E-01 |
| Obese-vs-Extreme_Obese |
8.232000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.516400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.78401999999522E-05 |
| Normal-vs-Age(61-80Yrs) |
4.66640004415098E-09 |
| Normal-vs-Age(81-100Yrs) |
4.17200000002449E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.581200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.339160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.182400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.547900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.146200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.438400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.8480999997017E-07 |
| Normal-VS-Type2 PRCC |
4.54030000041072E-07 |
| Normal-VS-KIRP CIMP |
2.260300E-02 |
| Normal-VS-Unclassified PRCC |
4.758300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.909200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.760200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.841600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.040000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.961400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.562000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.26739999606329E-08 |
| Normal-vs-N1 |
1.218540E-04 |
| Normal-vs-N2 |
5.57270000000054E-05 |
| N0-vs-N1 |
2.844200E-01 |
| N0-vs-N2 |
2.949000E-01 |
| N1-vs-N2 |
1.477810E-01 |
|
|
